interesting article!
From my reading, these are some of the highlights:
- Concepts development of TAVR during the 90s
- In 1999, a small startup Percutaneous Valve Technologies’ (PVT, NJ, USA) was finally formed to develop the TAVR prototypes
- In 2000, PVT started animal trial on sheep
- In April 2002, PVT performed the first in-human TAVR trial on a 57 y.o. Patient
- While undergoing further TAVR trials and development, Edwards Lifesciences Corporation (Irvine, CA, USA) acquired PVT in 2004 for $155 million. (https://www.google.com.au/amp/s/www.haaretz.com/amp/1.4788606). TAVR entered a new era.
- Forums
- ASX - By Stock
- AVR
- Why Admedus’ shift to aortic valve replacement is good news for patients under 65
Why Admedus’ shift to aortic valve replacement is good news for patients under 65, page-12
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.20 |
Change
0.050(0.33%) |
Mkt cap ! $292.1M |
Open | High | Low | Value | Volume |
$15.35 | $15.35 | $15.00 | $20.85K | 1.367K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 132 | $15.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.30 | 290 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 148 | 15.200 |
1 | 50 | 15.040 |
1 | 630 | 15.000 |
2 | 1651 | 14.950 |
1 | 300 | 14.900 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 4 | 1 |
15.300 | 288 | 1 |
15.570 | 35 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
Last trade - 10.50am 31/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online